Companion Animal Cancer Treatments Part 3: Immunotherapy, when is it appropriate?

Home / Companion Animal Cancer Treatments Part 3: Immunotherapy, when is it appropriate?
Daxeyesphoto.jpg

Companion Animal Cancer Treatments Part 3: Immunotherapy, when is it appropriate?

02:30 02 October in by Genevieve Scott

Welcome to part three of our multi-series blog post, designed to help you understand the treatments available for your furry friend when they are diagnosed with cancer. While there is no cure to cancer, we hope our insight will help you make the right decision as advised by your veterinarian.

Last we week we discussed Radiation and when this treatment usally prescribed. If you missed last week's article, click here to read it. This week we will be talking about Immunotherapy as a cancer treatment and when it is the right time to use it.

When is immunotherapy used to treat animals with cancer?

When an animal is diagnosed with a tumor that is immunogenic—recognized as foreign by the body—immunotherapy can be a very effective form of cancer treatment.

Immunotherapy treatment options use certain parts of an animal’s immune system to fight cancer. It is most often used to treat:

  • Lymphoma
  • Multiple Myeloma
  • Renal Cell Sarcoma
  • Hemangiosarcoma

Immunotherapies present an abundant choice of antigens that educates the patient’s immune system to recognize that the cancer is foreign, and increases the likelihood of responding to treatment.

Immunotherapies have been used to treat solid tumors such as:

  • Melanoma
  • Squamous Cell Carcinoma
  • Oral Fibrosarcoma
  • Oral Osteosarcoma
  • Soft Tissue Sarcoma
  • Basal Cell Carcinomas
  • Nerve Sheath Tumors
  • Hepatocellular Carcinoma
  • Nasal Carcinoma
  • Adenocarcinoma
  • Mast Cell Tumors
  • Transitional Cell

These treatments are typically administered via injections and/or infusions over time. Common side effects tend to include “flu-like” symptoms. However, one of the advantages of immunotherapy is that it is generally less toxic than chemotherapy.

At Vetrix, we’ve partnered with Torigen Pharmaceuticals to bring to market a whole cell tissue immunotherapy, utilizing the animal’s own tumor cells, that allows for a variety of tumor antigens to be presented to the immune system—VetiVax.

If you have a pet or patient with cancer and want to know more about VetiVax today, click the link below or give us a call at 678-278-8277.

Stay tuned over the next couple weeks, as we explore why immunotherapies are becoming a widely recognized treatment for your furry friend.